Plain Language Summary: The effects of iclepertin on cognition in people with schizophrenia
Many people affected by schizophrenia have difficulties with cognition; however, there are currently no approved drugs to treat cognitive impairment associated with schizophrenia.
This article, published in Future Neurology, is a plain language summary of an article originally published in Lancet Psychiatry, which looks at the drug iclepertin (BI 425809) and if it could improve cognition in people with schizophrenia.